Inside these posts: Neuro devices

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


$480M J&J deal heats up neuro-device market

Johnson & Johnson said Monday it plans to bolster its lineup of stroke-prevention products by buying Micrus Endovascular Corp. for about $480 million, marking the latest deal in a neurovascular-device market that appears to be heating up.

J&J’s planned purchase of San Jose, Calif.-based Micrus comes weeks after rival Covidien PLCĀ  announced plans to buy ev3 Corp. , a Micrus rival, for $2.6 billion. Leerink Swann analyst Rick Wise said the Covidien-ev3 combination may have spurred on J&J amid a trend of focusing more on bundled portfolios of products. Get the full story »